Fabino Enterprises share news and announcements

BSE: 543444Pharmaceuticals & Biotechnology

Last traded ₹20.31 on 27 Apr 2026

Fabino Enterprises share news and announcements

137 announcements, routine notices left out, newest first. Page 3 of 3.

Aug 2023
- 18 Aug · Meeting
  Intimation of Book Closure for 12th AGM to be held on September 12, 2023. (opens in a new tab)
Jul 2023
- 31 Jul · Business
  Announcement under Regulation 30 (LODR) - Acquisition (opens in a new tab)
- 29 Jul · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
  Please find enclosed disclosure under Regulation 30 (LODR) for Change in Registered Office of the Company. (opens in a new tab)
May 2023
- 30 May · Results
  In continuation of our letter dated May 17, 2023, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 30 May · Results
  In continuation of our letter dated May 17, 2023, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 24 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve In continuation of our .... (opens in a new tab)
- 17 May · Board meeting
  Meeting on 30 May 2023: audited results
- 17 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve In pursuant to Regulation .... (opens in a new tab)
- 2 May · Board meeting
  Meeting on 2 May 2023
- 2 May · Authorisation Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
  Pursuant to requirement under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the contact details of the Key Managerial Personnel ('KMP') who .... (opens in a new tab)
- 2 May · Management
  We wish to inform you that, Board has appointed in its meeting .... (opens in a new tab)
- 2 May · Board meeting
  Board of Directors of the Company at their meeting held today i.e. 02nd May, 2023 has inter alia, considered and approved the following: 1. Acceptance of Resignation of CS Aslam .... (opens in a new tab)
Apr 2023
- 25 Apr · Management
  We wish to inform you that, CS Aslam Mohammad has resigned .... (opens in a new tab)
- 18 Apr · Certificate As Per Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Year Ended March 31, 2023.
  Please find enclosed herewith the certificate dated April 18, 2023 from JNG & Co, Practicing Company Secretaries under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 18 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Year Ended March 31, 2023
  We hereby certify that all activities in relation to both physical and electronic .... (opens in a new tab)
Nov 2022
- 24 Nov · Board meeting
  In continuation of our letter dated November 02, 2022, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 9 Nov · Board meeting
  In continuation of our letter dated November 02, 2022, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 2 Nov · Board meeting
  Meeting on 9 Nov 2022: half yearly results
Sep 2022
Aug 2022
Jul 2022
- 26 Jul · Intimation For Shifting Of The Registered Office Of The Company
  We would like to inform you that consequent to confirmation of the Regional Director, Northern Region, Ministry of Corporate Affairs vide order dated June 29, 2022 for the shifting of Registered .... (opens in a new tab)
- 2 Jul · Intimation For Shifting Of The Registered Office Of The Company.
  We would like to inform you that consequent to confirmation of the Regional Director, Northern Region Ministry of Corporate Affairs New Delhi vide order dated 29.06.2022 for the shifting .... (opens in a new tab)
May 2022
- 24 May · Management
  Dear Sir/Madam, With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held today i.e. Tuesday, May 24, 2022 .... (opens in a new tab)
- 24 May · Board meeting
  In continuation of our letter dated May 17, 2022, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements .... (opens in a new tab)
- 17 May · Board meeting
  Meeting on 24 May 2022: audited results
Apr 2022
- 20 Apr · Certificate As Per Regulation 7(3) SEBI (Listing Obligation And Disclosures Requirements) Regulations, 2015 For Year Ended March 31, 2022
  We hereby certify that all activities in relation to both physical and electronic .... (opens in a new tab)
- 18 Apr · Certificate As Per Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Year Ended March 31, 2022
  Dear Sir/Madam, Please find enclosed herewith the certificate dated April 16, 2022 from Spanj & Associates, Practicing Company Secretaries under Regulation 40(9) of SEBI (Listing Obligations .... (opens in a new tab)
- 18 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
- 30 Mar · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aryaman Capital Markets Ltd (opens in a new tab)
Jan 2022
- 19 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 13 Jan · Listing of equity shares of Fabino Life Sciences Ltd
  Trading Members of the Exchange are hereby informed that effective from January 13, 2022 the equity shares of Fabino Life Sciences Ltd (Scrip Code: 543444) are listed and admitted to dealings ....